These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 32081280)

  • 21. Accurate diagnosis of apical hypertrophic cardiomyopathy using explainable advanced electrocardiogram analysis.
    Hughes RK; Thornton GD; Malcolmson JW; Pierce I; Khoury S; Hornell A; Knott K; Captur G; Moon JC; Schlegel TT; Ugander M
    Europace; 2024 Mar; 26(4):. PubMed ID: 38588067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A diagnostic method for cardiomyopathy based on multimodal data.
    Shen L; Zhang X; Huang S; Wu B; Li J
    Biomed Tech (Berl); 2023 Aug; 68(4):411-420. PubMed ID: 37013592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac magnetic field map topology quantified by Kullback-Leibler entropy identifies patients with hypertrophic cardiomyopathy.
    Schirdewan A; Gapelyuk A; Fischer R; Koch L; Schütt H; Zacharzowsky U; Dietz R; Thierfelder L; Wessel N
    Chaos; 2007 Mar; 17(1):015118. PubMed ID: 17411275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of hypertrophic cardiomyopathy in highly trained athletes: relevance to pre-participation screening.
    Basavarajaiah S; Wilson M; Whyte G; Shah A; McKenna W; Sharma S
    J Am Coll Cardiol; 2008 Mar; 51(10):1033-9. PubMed ID: 18325444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ST-segment depression as a risk factor in hypertrophic cardiomyopathy.
    Haghjoo M; Mohammadzadeh S; Taherpour M; Faghfurian B; Fazelifar AF; Alizadeh A; Rad MA; Sadr-Ameli MA
    Europace; 2009 May; 11(5):643-9. PubMed ID: 19164362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of the 12-lead surface electrocardiogram in sarcomeric hypertrophic cardiomyopathy: data from the REMY French register.
    Ledieu N; Larnier L; Auffret V; Marie C; Fargeau D; Donal E; Mirabel M; Jeunemaitre X; Puscas T; Marijon E; Reynaud A; Ritter P; Lafitte S; Mabo P; Réant P; Daubert C; Hagège AA;
    Europace; 2020 Jan; 22(1):139-148. PubMed ID: 31603495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy.
    Adabag AS; Casey SA; Kuskowski MA; Zenovich AG; Maron BJ
    J Am Coll Cardiol; 2005 Mar; 45(5):697-704. PubMed ID: 15734613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MYBPC3 hypertrophic cardiomyopathy can be detected by using advanced ECG in children and young adults.
    Fernlund E; Liuba P; Carlson J; Platonov PG; Schlegel TT
    J Electrocardiol; 2016; 49(3):392-400. PubMed ID: 27061026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patient-Level Artificial Intelligence-Enhanced Electrocardiography in Hypertrophic Cardiomyopathy: Longitudinal Treatment and Clinical Biomarker Correlations.
    Siontis KC; Abreau S; Attia ZI; Barrios JP; Dewland TA; Agarwal P; Balasubramanyam A; Li Y; Lester SJ; Masri A; Wang A; Sehnert AJ; Edelberg JM; Abraham TP; Friedman PA; Olgin JE; Noseworthy PA; Tison GH
    JACC Adv; 2023 Oct; 2(8):. PubMed ID: 38076758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electrocardiography Screening for Hypertrophic Cardiomyopathy.
    Campbell MJ; Zhou X; Han C; Abrishami H; Webster G; Miyake CY; Knilans TK; Czosek RJ
    Pacing Clin Electrophysiol; 2016 Sep; 39(9):944-50. PubMed ID: 27346569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multinational Federated Learning Approach to Train ECG and Echocardiogram Models for Hypertrophic Cardiomyopathy Detection.
    Goto S; Solanki D; John JE; Yagi R; Homilius M; Ichihara G; Katsumata Y; Gaggin HK; Itabashi Y; MacRae CA; Deo RC
    Circulation; 2022 Sep; 146(10):755-769. PubMed ID: 35916132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Derivation and Validation of a Screening Model for Hypertrophic Cardiomyopathy Based on Electrocardiogram Features.
    Guo L; Gao C; Yang W; Ma Z; Zhou M; Liu J; Shao H; Wang B; Hu G; Zhao H; Zhang L; Guo X; Huang C; Cui Z; Song D; Sun F; Liu L; Zhang F; Tao L
    Front Cardiovasc Med; 2022; 9():889523. PubMed ID: 35686042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel electrocardiographic features in carriers of hypertrophic cardiomyopathy causing sarcomeric mutations.
    Jalanko M; Heliö T; Mustonen P; Kokkonen J; Huhtala H; Laine M; Jääskeläinen P; Tarkiainen M; Lauerma K; Sipola P; Laakso M; Kuusisto J; Nikus K
    J Electrocardiol; 2018; 51(6):983-989. PubMed ID: 30497761
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of the electrocardiographic phenotype in risk stratification for sudden cardiac death in childhood hypertrophic cardiomyopathy.
    Norrish G; Topriceanu C; Qu C; Field E; Walsh H; Ziółkowska L; Olivotto I; Passantino S; Favilli S; Anastasakis A; Vlagkouli V; Weintraub R; King I; Biagini E; Ragni L; Prendiville T; Duignan S; McLeod K; Ilina M; Fernández A; Bökenkamp R; Baban A; Drago F; Kubuš P; Daubeney PEF; Chivers S; Sarquella-Brugada G; Cesar S; Marrone C; Medrano C; Alvarez Garcia-Roves R; Uzun O; Gran F; Castro FJ; Gimeno JR; Barriales-Villa R; Rueda F; Adwani S; Searle J; Bharucha T; Siles A; Usano A; Rasmussen TB; Jones CB; Kubo T; Mogensen J; Reinhardt Z; Cervi E; Elliott PM; Omar RZ; Kaski JP
    Eur J Prev Cardiol; 2022 Mar; 29(4):645-653. PubMed ID: 33772274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical meaning of isolated increase of QRS voltages in hypertrophic cardiomyopathy versus athlete's heart.
    Calore C; Zorzi A; Corrado D
    J Electrocardiol; 2015; 48(3):373-9. PubMed ID: 25595718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The usefulness of sST2 and galectin-3 as novel biomarkers for better risk stratification in hypertrophic cardiomyopathy.
    Gawor M; Śpiewak M; Janas J; Kożuch K; Wróbel A; Mazurkiewicz Ł; Baranowski R; Marczak M; Grzybowski J
    Kardiol Pol; 2017; 75(10):997-1004. PubMed ID: 28612913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toward ECG-based analysis of hypertrophic cardiomyopathy: a novel ECG segmentation method for handling abnormalities.
    Nezamabadi K; Mayfield J; Li P; Greenland GV; Rodriguez S; Simsek B; Mousavi P; Shatkay H; Abraham MR
    J Am Med Inform Assoc; 2022 Oct; 29(11):1879-1889. PubMed ID: 35923089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical significance of left ventricular apical aneurysms in hypertrophic cardiomyopathy patients: the role of diagnostic electrocardiography.
    Ichida M; Nishimura Y; Kario K
    J Cardiol; 2014 Oct; 64(4):265-72. PubMed ID: 24674752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of subcutaneous implantable cardioverter-defibrillator candidacy based on template ECG screening in patients with hypertrophic cardiomyopathy.
    Maurizi N; Olivotto I; Olde Nordkamp LR; Baldini K; Fumagalli C; Brouwer TF; Knops RE; Cecchi F
    Heart Rhythm; 2016 Feb; 13(2):457-63. PubMed ID: 26362577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic accuracy of extended-length electrocardiogram in differentiating between athlete's heart and hypertrophic cardiomyopathy.
    Caselli L; Galanti G; Padeletti L; Nieri M; Cecchi F; Cipollini F; Baldi M; Perrotta L; Vignini S; Michelucci A
    J Electrocardiol; 2009; 42(6):636-41. PubMed ID: 19577245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.